GL
GLAPF.US Glanbia plc
- Market cap
- USD 5.09B
- P/E
- 21.7x
- P/B
- 2.69x
- ROE
- 31.8%
- Dividend yield
- 2.41%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is GLAPF.US undervalued?
Graham numberGLAPF.US trades 61.1% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Glanbia plc fundamental analysis
No fundamental analysis for Glanbia plc yet.
Glanbia plc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Glanbia plc
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing business; property and la…
Full company profileGlanbia plc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Glanbia plc annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 2.23B | 2.39B | 2.39B | 3.88B | 3.82B | 4.20B | 5.55B | 5.97B | 3.98B | 4.11B | 8.14B |
| Gross Profit | 781M | 645M | 680M | 761M | 689M | 831M | 955M | 1.24B | 1.21B | 1.03B | 2.17B |
| Operating Income | 222M | 215M | 242M | 177M | 114M | 158M | 220M | 390M | 243M | 365M | 825M |
| EBITDA | 331M | 343M | 330M | 313M | 300M | 328M | 411M | 617M | 402M | 520M | 1.09B |
| Net Income | 212M | 329M | 268M | 180M | 144M | 167M | 253M | 343M | 171M | 191M | 602M |
| EPS | 0.72 | 1.11 | 0.90 | 0.61 | 0.49 | 0.57 | 0.86 | 1.27 | 0.64 | 0.75 | 2.47 |
| Balance Sheet | |||||||||||
| Total Assets | 2.71B | 2.48B | 3.16B | 3.40B | 3.07B | 3.63B | 3.86B | 4.18B | 3.87B | 3.97B | 3.99B |
| Total Liabilities | 1.48B | 1.10B | 1.51B | 1.70B | 1.45B | 1.89B | 1.99B | 1.83B | 1.80B | 2.05B | 2.10B |
| Shareholders' Equity | 1.22B | 1.38B | 1.59B | 1.70B | 1.61B | 1.73B | 1.86B | 2.35B | 2.07B | 1.93B | 1.89B |
| Cash & Short-term Investments | 219M | 162M | 225M | 269M | 164M | 231M | 439M | 455M | 417M | 491M | 375M |
| Total Debt | 656M | 530M | 801M | 883M | 889M | 953M | 1.06B | 849M | 959M | 1.13B | 1.21B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 339M | 109M | 275M | 213M | 277M | 251M | 298M | 470M | 443M | 396M | 235M |
| Capital Expenditure | 89.5M | 72.5M | 62.6M | 76.3M | 64.2M | 77.5M | 68.9M | 81.6M | 87.1M | 51.6M | 135M |
| Free Cash Flow | 233M | 18.6M | 213M | 136M | 213M | 174M | 229M | 389M | 356M | 345M | 99.5M |
| Ratios | |||||||||||
| ROE | 17.4% | 23.8% | 16.8% | 10.6% | 8.9% | 9.6% | 13.6% | 14.6% | 8.2% | 9.9% | 31.8% |
| ROA | 7.8% | 13.3% | 8.5% | 5.3% | 4.7% | 4.6% | 6.6% | 8.2% | 4.4% | 4.8% | 15.1% |
| Net Profit Margin | 9.5% | 13.8% | 11.2% | 4.6% | 3.8% | 4.0% | 4.6% | 5.7% | 4.3% | 4.6% | 7.4% |
| Debt to Equity | 0.54x | 0.38x | 0.50x | 0.52x | 0.55x | 0.55x | 0.57x | 0.36x | 0.46x | 0.58x | 0.64x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Glanbia plc dividends
- Dividend yield
- 2.41%
- Forward dividend
- 0.51 USD
- Payout ratio
- 64.3%
- Ex-dividend date
- Aug 20, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 123M | 0.48 | 64.3% |
| 2024 | USD 104M | 0.39 | 61.2% |
| 2023 | USD 107M | 0.40 | 31.2% |
| 2022 | EUR 84.4M | 0.29 | 33.3% |
| 2021 | USD 80.5M | 0.27 | 48.2% |
| 2020 | USD 78.6M | 0.27 | 54.7% |
| 2019 | USD 74.3M | 0.25 | 41.2% |
| 2018 | USD 76.0M | 0.26 | 28.4% |
| 2017 | USD 49.2M | 0.17 | 14.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Glanbia plc
- Insiders 14.37%
- Institutions 34.43%
- Public & others 51.20%
- Shares outstanding 242M
- Free float 209M
Glanbia plc company profile
- Company name
- Glanbia plc
- Ticker
- GLAPF.US
- ISIN
- IE0000669501
- Exchange
- USA Stocks
- Sector
- Consumer Defensive
- Industry
- Food Products
- Employees
- 4,963
- Fiscal year end
- December
- Address
- Leggetsrath Business Park, Kilkenny, Ireland, R95 YTD5
- Phone
- 353 56 777 2200
- Website
- glanbia.com
About Glanbia plc
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing business; property and land dealing business; property leasing; provision of business services and management solutions; and bioactive solutions. It offers its products under the Optimum Nutrition, BSN, Isopure, Nutramino, think!, Amazing Grass brands. The company sells its products through specialty retail, online, gym, and food, drug, mass, and club channels. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.
Glanbia plc management
10- Mr. Hugh McGuire Dip Finance, M.ScCEO & Executive Director · born 1971
- Mr. Mark A. GarveyCFO & Executive Director · born 1964
- Mr. Liam HenniganGroup Secretary & Head of Investor Relations
- Mr. Ian DoyleChief Corporate Development Officer · born 1978
- Ms. Aisling ZitoChief Human Resources Officer
- Mr. Tom TenchCEO Dairy Nutrition · born 1971
- Ms. Wendy Chang SmithChief Digital & Transformation Officer
- Ms. Sorcha McKennaChief Strategy Officer
- Mr. Steve WatersChief Supply Chain Officer
- Mr. Brian Phelan B. Comm, FCAChief Executive Officer of Glanbia Nutritionals · born 1967